Discontinued — last reported Q4 '25

Financing

Share Buybacks

STERIS Share Buybacks decreased by 50.1% to $50.10M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 50.1%, from $100.50M to $50.10M. Over 3 years (FY 2022 to FY 2025), Share Buybacks shows an upward trend with a 55.9% CAGR.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2014
Last reportedQ4 2025

How to read this metric

High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.

Detailed definition

The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...

Peer comparison

Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.

Metric ID: share_repurchases

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$10.67M$14.08M$2.88M$28.15M$24.68M$45.24M$84.03M$154.61M$8.72M$489.00K$2.23M$325.00K$64.20M$46.42M$100.50M$221.00K$10.60M$100.50M$50.10M
QoQ Change+32.0%-79.6%+878.4%-12.3%+83.3%+85.7%+84.0%-94.4%-94.4%+355.6%-85.4%>999%-27.7%+116.5%-99.8%>999%+848.1%-50.1%
YoY Change+131.3%+221.3%>999%+449.3%-64.7%-98.9%-97.3%-99.8%+635.9%>999%>999%-32.0%-83.5%+116.5%-50.1%
Range$221.00K$154.61M
CAGR+41.0%
Avg YoY Growth>999%
Median YoY Growth+116.5%

Frequently Asked Questions

What is STERIS's share buybacks?
STERIS (STE) reported share buybacks of $50.10M in Q4 2025.
How has STERIS's share buybacks changed year-over-year?
STERIS's share buybacks decreased by 50.1% year-over-year, from $100.50M to $50.10M.
What is the long-term trend for STERIS's share buybacks?
Over 3 years (2022 to 2025), STERIS's share buybacks has grown at a 55.9% compound annual growth rate (CAGR), from $55.78M to $211.34M.
What does share buybacks mean?
Cash spent by the company to buy back its own stock.